Background To estimate the potential cost savings by following the current Global Initiative
for Chronic Obstructive Lung Disease (GOLD) guideline recommendations in patients being …

Background This study aimed to assess the adherence rate of pharmacological treatment to
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline published in …

Objectives: Chronic obstructive pulmonary disease (COPD) is an irreversible and often
progressive disease that requires lifelong adherence to complicated drug therapy regimens …

Introduction Several dual bronchodilator fixed‐dose inhaler medications were recently
approved for the treatment of chronic obstructive pulmonary disease (COPD). These …

Background The patterns of medication use in chronic obstructive pulmonary disease
(COPD) may change over time due to the availability of new medications, updates in …

Purpose Even with the dissemination of several clinical guidelines, chronic obstructive
pulmonary disease (COPD) remains underdiagnosed and mismanaged by many primary …

Background Chronic obstructive pulmonary disease (COPD) is the only leading cause of
death with rising morbidity and mortality. Clinical practice guidelines (CPGs) to optimize …

ABSTRACT OBJECTIVE We tested the hypothesis that use of and adherence to
maintenance medication is low among in-dividuals in the general population who have …

Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

Background Prescriber disagreement is among the reasons for poor adherence to COPD
treatment guidelines; it is yet not clear whether this leads to adverse outcomes. We tested …